Transport across biologioal barriers

Nanotherapeutics: Drug Delivery Concepts in Nanoscience

Volumn , Issue , 2008, Pages 39-66

  Nafee, Noha ^a,b   Bhardwaj, Vivekanand ^b,c   Schneider, Marc ^b  

^a ALEXANDRIA UNIVERSITY   (Egypt)

^b SAARLAND UNIVERSITY   (Germany)

^c NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84881972127     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4032/9789814241168     Document Type: Chapter

References (157)

1. Ainbinder, D. and Touitou, E. (2005). Testosterone ethosomes for enhanced transdermal delivery. Drug Deliv., 12, pp. 297-303.
2. Ajima, K., Yudasaka, M., Murakami, T., Maigne, A., Shiba, K. and Iijima, S. (2005). Carbon nanohoms as anticancer drug carriers. Molecular Pharmaceutics, 2(6), pp.475-480.
3. Alexiou, C., Arnold, W., Hulin, P., Klein, R. J., Renz, H., Parak, F. G., Bergemann, C. and Lübbe, A. S. (2001). Magnetic mitoxantrone nanoparticle detection by histology, X-ray and MRI after magnetic tumor targeting. J. Magnet. Magnetic Mat., 225, pp. 187-193.
4. Alexiou, C., Jurgons, R., Schmid, R. J., Bergemann, C., Henke, J., Erhardt, W., Huenges, E. and Parak, F. (2003). Magnetic drug targeting - Biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment. J. Drug Target., 11, pp. 139-149.
5. Alexiou, C., Schmid, R. J., Jurgons, R., Kremer, M., Wanner, G., Bergemann, c., Huenges, E., Nawroth, T., Arnold, W. and Parak, F. G. (2006). Targeting cancer cells: Magnetic nanoparticles as drug carriers. Eur. Biophys. J., 35, pp. 446-450.
6. Alonso, M. J. (2004). Nanomedicines for overcoming biological barriers. Biomed. Pharmacotherap., 58, pp. 168-172.
7. Alvarez-Roman, R., Naik, A., Kalia, Y. N., Guy, R. H. and Fessi, H. (2004). Enhancement of topical delivery from biodegradable nanoparticles. Pharm. Res., 21, pp. 1818-1825.
8. Baughman, R. H., Zakhidov, A. A. and De Heer, W. A. (2002). Carbon nanotubes - The route toward applications. Science, 297, pp. 787-792.
9. Bharali, D. J., Lucey, D. W., Jayakumar, H., Pudavar, H. E. and Prasad, P. N. (2005). Folate-Receptor-Mediated Delivery of InP Quantum Dots for Bioimaging Using Confocal and Two-Photon Microscopy. pp. 11364-11371.
10. Bianco, A. (2004). Carbon nanotubes for the delivery of therapeutic molecules. Expert Opin. Drug Deliv., 1, pp. 57-65.
11. Bivas-Benita, M., Romeijn, S., Junginger, H. E. and Borchard, G. (2004). PLGA-PEI nanoparticles for gene delivery to pulmonary epithelium. Eur. J. Pharm. Biopharm., 58, pp. 1-6.
12. Boussif, O., Lezoualc'h, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B. and Behr, J. (1995). A Versatile Vector for Gene and Oligonucleotide Transfer into Cells in Culture and in vivo: Polyethylenimine. Proc. Nat. A cad. Sci., 92, pp.7297-7301.
13. Brannon-Peppas, L. and Blanchette, J. O. (2004). Nanoparticle and targeted systems for cancer therapy. Adv. Drug Deliv. Rev., 56, pp. 1649-1659.
14. Cagle, D. W., Kennel, S. J., Mirzadeh, S., Alford, J. M. and Wilson, L. J. (1999). In vivo studies of fullerene-based materials using endohedral metallofullerene radiotracers. Proc. Nat. Acad. Sci., 96, pp. 5182-5187.
15. Chan, W. C. and Nie, S. (1998). Quantum Dot Bioconjugates for Ultrasensitive Nonisotopic Detection. Science, 281, pp. 2016-2018.
16. Chen, F. and Gerion, D. (2004). Fluorescent CdSe/ZnS Nanocrystal-Peptide Conjugates for Long-term, Nontoxic Imaging and Nuclear Targeting in Living Cells. Nano Lett., 4, pp. 1827-1832.
17. Cohen-Sacks, H., Elazar, V., Gao, J., Golomb, A., Adwan, H., Korchov, N., Levy, R. J., Berger, M. R. and Golomb, G. (2004). Delivery and expression of pDNA embedded in collagen matrices. J. Control. Rel., 95, pp. 309-320.
18. Costantino, L., Gandolfi, F., Bossy-Nobs, L., Tosi, G., Gurny, R., Rivasi, F., Angela Vandelli, M. and Forni, F. (2006). Nanoparticulate drug carriers based on hybrid poly(d,l-lactide-co-glycolide)-dendron structures. Biomaterials, 27, pp. 4635-4645.
19. Csaba, N., Sanchez, A. and Alonso, M. J. (2006). PLGA:Poloxamer and PLGA:Poloxamine blend nanostructures as carriers for nasal gene delivery. J. Control. Rei., 113, pp. 164-172.
20. Cui, D., Ozkan, C. S., Ravindran, S., Kong, Y. and Gao, H. (2004). Encapsulation of Ptlabelled DNA Molecules inside Carbon Nanotubes. Mech. Chem. Biosystems, 1, pp. 113-122.
21. Cui, D., Tian, F., Ozkan, C. S., Wang, M. and Gao, H. (2005). Effect of single wall carbon nanotubes on human HEK293 cells. Tox. Lett., 155, pp. 73-85.
22. D'Emanuele, A., Jevprasesphant, R., Penny, J. and Attwood, D. (2004). The use of a dendrimer-propranolol prodrug to bypass efflux transporters and enhance oral bioavailability. Journal of Controlled Release, 95(3), pp. 447-453.
23. Dang, J. M. and Leong, K. W. (2006). Natural polymers for gene delivery and tissue engineering. Adv. Drug Deliv. Rev., 58, pp. 487-499.
24. Danielsen, S., Strand, S., de Lange Davies, C. and Stokke, B. T. (2005). Glycosaminoglycan destabilization of DNA-chitosan polypI exes for gene delivery depends on chitosan chain length and GAG properties. Biochim. Biophys. Acta, 1721, pp. 44-54.
25. De Geest, B. G., Déjugnat, C., Verhoeven, E., Sukhorukov, G. B., Jonas, A. M., Plain, J., Demeester, J. and De Smedt, S. C. (2006 a). Layer-by-Layer coating of degradable microgels for pulsed drug delivery. J. Control. Rei., 116, pp. 159-169.
26. De Geest, B. G., Stubbe, B. G., Jonas, A. M., Van Thienen, T., Hinrichs, W. L. J., Demeester, J. and De Smedt, S. C. (2006 b). Self-exploding lipid-coated microgels. Biomacromolecules, 7, pp. 373-379.
27. Decher, G. and Hong, J. D. (1991). Buildup of Ultrathin Multilayer Films by a SelfAssembly Process 2. Consecutive Adsorption of Anionic and Cationic Bipolar Amphiphiles and Polyelectrolytes on Charged Surfaces. Phys. Chem. Chem. Phys., 95, pp.1430-1434.
28. Desai, M. P., Labhasetwar, V., Amidon, G. L. and Levy, R. J. (1996). Gastrointestinal uptake of biodegradable microparticles, pp. Effect of particle size. Pharm. Res., 13, pp. 1838-1845.
29. Dodane, V., Amin Khan, M. and Merwin, J. R. (1999). Effect of chitosan on epithelial penneability and structure. I.J. Pharm., 182, pp. 21-32.
30. Dutton, A. R., Tokuyasu, K. T. and Singer, S. J. (1979). Iron-dextran antibody conjugates, pp. General method for simultaneous staining of two components in high-resolution immunoelectron microscopy. Proc. Nat. Acad. Sci., 76, pp. 3392- 3396.
31. Egbaria, K., Ramachandran, C. and Weiner, N. (1990). Topical delivery of ciclosporin, pp. Evaluation of various fonnulations using in vitro diffusion studies in hairless mouse skin. Skin Pharmacol., 3, pp. 21-28.
32. El-Sayed, M., Ginski, M., Rhodes, C. and Ghandehari, H. (2002). Transepithelial transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers. J. Control. Rel., 81, pp. 355-365.
33. El-Sayed, M., Rhodes, C. A., Ginski, M. and Ghandehari, R. (2003). Transport mechanism(s) of poly (amidoamine) dendrimers across Caco-2 cell monolayers. Int. J. Pharm., 265, pp. 151-157.
34. El-Shabouri, M. H. (2002). Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A. Int. J. Pharm., 249, pp. 101-108.
35. El Ouahabi, A., Thiry, M., Pector, V., Fuks, R., Ruysschaert, J. M. and Vandenbranden, M. (1997). The role of endosome destabilizing activity in the gene transfer process mediated by cationic lipids. FEBS Letters, 414, pp. 187-192.
36. Fahmy, T. M., Fong, P. M., Goyal, A. and Saltzman, W. M. (2005). Targeted for drug delivery. Materials Today, 8, pp. 18-26.
37. Felberbaum-Corti, M., Van Der Goot, F. G. and Gruenberg, J. (2003). Sliding doors: Clathrin-coated pits or caveolae? Nat. Cell Biol., 5, pp. 382-384.
38. Felgner, J. R., Kumar, R., Sridhar, C. N., Wheeler, C. J., Tsai, Y. J., Border, R., Ramsey, P., Martin, M. and Felgner, P. L. (1994). Enhanced gene delivery and mechanism studies with a novel series of cationic lipid fonnulations. J. Bioi. Chern., 269, pp.2550-2561.
39. Ferrari, M. (2005). Cancer nanotechnology: Opportunities and challenges. Nat. Rev. Cancer, S, pp. 161-171.
40. Foldvari, M. (1994). In vitro cutaneous and percutaneous delivery and in vivo efficacy of tetracaine from liposomal and conventional vehicles. Pharm. Res., 11, pp. 1593- 1598.
41. Friedman, S. R., DeCamp, D. L., Sijbesma, R. P., Srdanov, G., Wudl, F. and Kenyon, G. L. (1993). Inhibition of the HIV-I protease by fullerene derivatives: Model building studies and experimental verification. J. Am. Chern. Soc., 115, pp. 6506- 6509.
42. Gan, Q., Wang, T., Cochrane, C. and McCarron, P. (2005). Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery. Coll. Suif. B: Biointeif., 44, pp. 65-73.
43. Gao, H., Kong, Y., Cui, D. and Ozkan, C. S. (2003). Spontaneous insertion of DNA oligonucleotides into carbon nanotubes. Nano Lett., 3, pp. 471-473.
44. Gao, S., Chen, J., Dong, L., Ding, Z., Yang, Y.-h. and Zhang, J. (2005). Targeting delivery of oligonucleotide and plasmid DNA to hepatocyte via galactosylated chitosan vector. Eur. J. Pharm. Biopharm., 60, pp. 327-334.
45. Ghadiri, M. R., Granja, J. R., Milligan, R. A., McRee, D. E. and Khazanovich, N. (1993). Self-assembling organic nanotubes based on a cyclic peptide architecture. Nature, 366, pp. 324-327.
46. Hariharan, S., Bhardwaj, V., Bala, I., Sitterberg, J., Bakowsky, U. and Ravi Kumar, M. N. V. (2006). Design of estradiol loaded PLGA nanoparticulate formulations: A potential oral delivery system for hormone therapy. Pharm. Res., 23, pp. 184-195.
47. Hashida, M., Nishikawa, M., Yamashita, F. and Takakura, Y. (2001). Cell-specific delivery of genes with glycosylated carriers. Adv. Drug Deliv. Rev., 52, pp. 187- 196.
48. Heeremans, J. L. M., Prevost, R., Bekkers, M. E. A., Los, P., Emeis, J. J., Kluft, C. and Crommelin, D. J. A. (1995). Thrombolytic treatment with tissue-type plasminogen activator (t-PA) containing liposomes in rabbits: A comparison with free t-PA. Thromb. Haemost., 73, pp. 488-494.
49. Hidalgo, I. J. (2001). Assessing the absorption of new pharmaceuticals. Curro Topics Med. Chem. 1, pp. 385-40l.
50. Hirsch, L. R., Gobin, A. M., Lowery, A. R., Tam, F., Drezek, R. A., Halas, N. J. and West, J. L. (2006). Metal nanoshells. Ann. Biomed. Engin., 34, pp. 15-22.
51. Hoshino, A., Fujioka, K, Oku, T., Nakamura, S., Suga, M., Yamaguchi, Y., Suzuki, K, Yasuhara, M. and Yamamoto, K (2004). Quantum dots targeted to the assigned organelle in living cells. Microbiol. Immun., 48, pp. 985-994.
52. Huang, M., Khor, E. and Lim, L.-Y. (2004). Uptake and cytotoxicity of chitosan molecules and nanparticles: effects of molecular weight and degree of deacetylation. Pharm. Res., 21, pp. 344-353.
53. Hummer, G., Rasaiah, J. C. and Noworyta, J. P. (2001). Water conduction through the hydrophobic channel of a carbon nanotube. Nature, 414, pp. 188-190.
54. Iijima, S. (1991). Helical microtubu1es of graphitic carbon. Nature, 354, pp. 56-58.
55. Iijima, S., Yudasaka, M., Yamada, R., Bandow, S., Suenaga, K, Kokai, F. and Takahashi, K (1999). Nano-aggregates of single-walled graphitic carbon nanohorns. Chem. Phys. Lett., 309, pp. 165-170.
56. Isobe, H., Nakanishi, W., Tomita, N., Jinno, S., Okayama, H. and Nakamura, E. (2006). Gene delivery by aminofullerenes: Structural requirements for efficient transfection. Chemistry -An Asian Journal, 1, pp. 167-175.
57. Issa, M. M., Koping-Hoggard, M., Tommeraas, K, Vamm, K. M., Christensen, B. E., Strand, S. P. and Artursson, P. (2006). Targeted gene delivery with trisaccharide substituted chitosan oligomers in vitro and after lung administration in vivo. J. Control. Rel., 115, pp. 103-112.
58. Ito, A., Shinkai, M., Honda, H. and Kobayashi, T. (2005). Medical Application of Functionalized Magnetic Nanoparticles. J. Biosci. Bioengin., 100, pp. 1-11.
59. Ito, T., Sun, L. and Crooks, R. M. (2003). Observation of DNA transport through a single carbon nanotube channel using fluorescence microscopy. Chem. Comm., 9, pp.1482-1483.
60. Jaiswal, J. K., Mattoussi, H., Mauro, J. M. and Simon, S. M. (2003). Long-term mUltiple color imaging of live cells using quantum dot bioconjugates. Nat. Biotech., 21, pp.47-51.
61. Janes, K. A., Calvo, P. and Alonso, M. J. (2001). Polysaccharide colloidal particles as delivery systems for macromolecules. Adv. Drug Deliv. Rev., 47, pp. 83-97.
62. Jani, P., Halbert, G. W., Langridge, J. and Florence, A. T. (1990). Nanoparticle uptake by the rat gastrointestinal mucosa: Quantitation and particle size dependency. J. Pharm. Pharmacol., 42, pp. 821-826.
63. Jasmina, L., Hassan, S. B., Yan, C., Genevieve, R. A. F., Françoise, M. W. and Dusica, M. (2005). Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots. J. Mol. Med., V83, pp. 377-385.
64. Jung, S., Otberg, N., Thiede, G., Richter, H., Sterry, W., Panzner, S. and Lademann, J. (2006). Innovative liposomes as a transfollicular drug delivery system: Penetration into porcine hair follicles. J. Invest. Dermatol., 126, pp. 1728-1732.
65. Jung, T., Kamm, W., Breitenbach, A., Hungerer, K.-D., Hundt, E. and Kissel, T. (2001). Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graftpoly(lactide-co-glycolide): Evaluation of antibody response after oral and nasal application in mice. Pharm. Res., 18, pp. 352-360.
66. Kalra, A., Garde, S. and Hummer, G. (2003). Osmotic water transport through carbon nanotube membranes. Proc. Nat. Acad. Sci., 100, pp. 10175-10180.
67. Kam, N. W. S., Jessop, T. c., Wender, P. A. and Dai, H. J. (2004). Nanotube molecular transporters: Internalization of carbon nanotube-protein conjugates into mammalian cells. J. Am. Chem. Soc., pp. 6850-6851.
68. Kaneda, Y. and Tabata, Y. (2006). Non-viral vectors for cancer therapy. Cancer Sci., 97, pp.348-354.
69. Kean, T., Roth, S. and Thanou, M. (2005). Trimethylated chitosans as non-viral gene delivery vectors: Cytotoxicity and transfection efficiency. J. Control. Rel., 103, pp.643-653.
70. Kim, G. J. and Nie, S. (2005). Targeted cancer nanotherapy. Materials Today, 8, pp. 28- 33.
71. Kircheis, R., Wightman, L. and Wagner, E. (2001). Design and gene delivery activity of modified polyethylenimines. Adv. Drug Deliv. Rev., 53, pp. 341-358.
72. Kitchens, K. M., El-Sayed, M. E. H. and Ghandehari, H. (2005). Transepithelial and endothelial transport of poly (amidoamine) dendrimers. Adv. Drug Deliv. Rev., 57, pp.2163-2176.
73. Kloepfer, J. A., Mielke, R. E. and Nadeau, J. L. (2005). Uptake of CdSe and CdSe/ZnS Quantum Dots into Bacteria via Purine-Dependent Mechanisms. Appl. Environ. Microbiol., 71, pp. 2548-2557.
74. Koltover, I., Salditt, T., Radler, J. O. and Safinya, C. R. (1998). An Inverted Hexagonal Phase of Cationic Liposome-DNA Complexes Related to DNA Release and Delivery. Science, 281, pp. 78-81.
75. Korting, H. c., Zienicke, H., Schafer-Korting, M. and Braun-Falco, O. (1990). Liposome encapsulation improves efficacy of betamethasone dipropionate in atopic eczema but not in psoriasis vulgaris. Eur. J. Clin. Pharmacol., 39, pp. 349-351.
76. Kroll, R. A., Pagel, M. A., Muldoon, L. L., Roman-Goldstein, S., Fiamengo, S. A. and Neuwelt, E. A. (1998). Improving drug delivery to intracerebral tumor and surrounding brain in a rodent model: a comparison of osmotic versus bradykinin modification of the blood brain and/or blood tumor barriers. Neurosurgery, 43, pp. 879-886.
77. Kroto, H. W., Heath, J. R., O'Brien, S. C., Curl, R. F. and Smalley, R. E. (1985). C-60- Buckminsterfullerene. Nature, 318, pp. 162-163.
78. Labhasetwar, V. (2005). Nanotechnology for drug and gene therapy: The importance of understanding molecular mechanisms of delivery. Curro Opin. Biotech., 16, pp. 674-680.
79. Lamprecht, A., Schäfer, U. and Lehr, C.-M. (2001). Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa. Pharm. Res., 18, pp. 788-793.
80. Lidke, D. S., Nagy, P., Heintzmann, R., Arndt-Jovin, D. J., Post, J. N., Grecco, H. E., Jares-Erijman, E. A. and Jovin, T. M. (2004). Quantum dot ligands provide new insights into erbB/HER receptor-mediated signal transduction. Nat. Biotech., 22, pp. 198-203.
81. Lindgren, M. E., Hallbrink, M. M., Elmquist, A. M. and Langel, U. (2004). Passage of cell-penetrating peptides across a human epithelial cell layer in vitro. Biochem. J., 377, pp. 69-76.
82. Liu, X., Gao, C., Shen, J. and Möhwald, H. (2005). Multilayer microcapsules as anticancer drug delivery vehicle: Deposition, sustained release, and in vitro bioactivity. Macromoi. Biosci., 5, pp. 1209-1219.
83. Luengo, J., Weiss, B., Schneider, M., Ehlers, A., Stracke, F., König, K., Kostka, K.-H., Lehr, C.-M. and Schaefer, U. F. (2006). Influence of Nanoencapsulation on Human Skin Transport of Flufenamic Acid. Skin Pharmacol. Physiol., 19, pp. 190-197.
84. Luo, D. and Saltzman, W. M. (2006). Nonviral gene delivery: Thinking of silica. Gene Ther., 13, pp. 585-586.
85. Luo, Y., Chen, D., Ren, L., Zhao, X. and Qin, J. (2006). Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability. J. Control. Rei., 114, pp. 53-59.
86. Maeda, H., Sawa, T. and Konno, T. (2001). Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J. Control. Rel., 74, pp. 47- 6J.
87. Maeda, H., Wu, J., Sawa, T., Matsumura, Y. and Hori, K. (2000). Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Rel., 65, pp. 271-284.
88. Mansouri, S., Lavigne, P., Corsi, K., Benderdour, M., Beaumont, E. and Fernandes, J. C. (2004). Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy. Eur. J. Pharm. Biopharm., 57, pp. 1-8.
89. Martin, C. R. and Kohli, P. (2003). The emerging field of nanotube biotechnology. Nat. Rev. Drug Discov., 2, pp. 29-37.
90. Matsumura, Y. and Maeda, H. (1986). A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res., 46, pp. 6387-6392.
91. Maysinger, D., Lovric, J., Eisenberg, A. and Savic, R. (2007). Fate of micelles and quantum dots in cells. Eur. J. Pharm. Biopharm., 65, pp. 270-28J.
92. Mehta, R. V., Upadhyay, R. V., Charles, S. W. and Ramchand, C. N. (1997). Direct binding of protein to magnetic particles. Biotech. Techn., 11, pp. 493-496.
93. Mezei, M. and Gulasekharam, V. (1980). Liposomes - a selective drug delivery system for the topical route of administration. I. Lotion dosage form. Life Sci., 26, pp. 1473-1477.
94. Molday, R. S. and Mackenzie, D. (1982). Immunospecific ferromagnetic iron-dextran reagents for the labeling and magnetic separation of cells. J. Immun. Methods, 52(3), pp. 353-367.
95. Mueller, R. H., Runge, S., Ravelli, V., Mehnert, W., Thunemann, A. F. and Souto, E. B. (2006). Oral bioavailability of cyclosporine: Solid lipid nanoparticles (SLN®) versus drug nanocrystals. Int. J. Pharm., 317, pp. 82-89.
96. Munier, S., Messai, I., Delair, T., Verrier, B. and Ataman-Onal, Y. (2005). Cationic PLA nanoparticles for DNA delivery: Comparison of three surface polycations for DNA binding, protection and transfection properties. Colloids and Suifaces B: Biointeifaces, 43, pp. 163-173.
97. Nel, A., Xia, T., Mad1er, L. and Li, N. (2006). Toxic Potential of Materials at the Nanolevel. Science, 311, pp. 622-627.
98. O'Neal, D. P., Hirsch, L. R., Halas, N. J., Payne, J. D. and West, J. L. (2004). Photothermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett., 209, pp. 171-176.
99. Owens III, D. E. and Peppas, N. A. (2006). Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm., 307, pp. 93-102.
100. Paciotti, G. F., Kingston, D. G. I. and Tamarkin, L. (2006). Colloidal gold nanoparticles: A novel nanoparticle platform for developing multifunctional tumor-targeted drug delivery vectors. Drug Dev. Res., 67, pp. 47-54.
101. Pantarotto, D., Briand, J. P., Prato, M. and Bianco, A. (2004). Translocation ofbioactive peptides across cell membranes by carbon nanotubes. Chem. Comm., 1, pp. 16-17.
102. Panyam, J. and Labhasetwar, V. (2003a). Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev., 55, pp. 329-347.
103. Panyam, J. and Labhasetwar, V. (2003b). Dynamics of endocytosis and exocytosis of poly (D,L-Iactide-co-glycolide) nanopartilces in vascular smooth muscle cells. Pharm. Res., 20, pp. 110-118.
104. Panyam, J., Zhou, W.-Z., Prabha, S., Sahoo, S. K. and Labhasetwar, V. (2002). Rapid endo-Iysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: Implications for drug and gene delivery. FASEB Journal, 16, pp. 1217-1226.
105. Pardridge, W. M. (2006). Molecular Trojan horses for blood-brain barrier drug delivery. Curro Opin. Pharmacol., 6, pp. 494-500.
106. Park, T. G., Jeong, J. H. and Kim, S. W. (2006). Current status of polymeric gene delivery systems. Adv. Drug Deliv. Rev., 58, pp. 467-486.
107. Qian, Z. M., Li, H., Sun, H. and Ho, K. (2002). Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol. Rev., 54, pp. 561-587.
108. Ravi Kumar, M. N. V., Mohapatra, S. S., Kong, X., Jena, P. K., Bakowsky, U. and Lehr, C.-M. (2004). Cationic poly(lactide-co-glycolide) nanoparticles as efficient in vivo gene transfection agents. J. Nanosci. Nanotech., 4, pp. 1-5.
109. Rejman, J., Oberle, V., Zuhorn, I. S. and Hoekstra, D. (2004). Size-dependent internalization of particles via the pathways of clathrin-and caveolae-mediated endocytosis. Biochem. J., 377, pp. 159-169.
110. Renshaw, P. F., Owen, C. S. and McLaughlin, A. C. (1986). Ferromagnetic contrast agents: A new approach. Magn. Res. Med., 3, pp. 217-225.
111. Ruedeekorn, W., Begoña C. G., Navid, M. and Ruth, D. (2000). Anionic PAMAM Dendrimers Rapidly Cross Adult Rat Intestine In Vitro: A Potential Oral Delivery System. Pharm. Res., 17, pp. 991-998.
112. Sahoo, S. K. and Labhasetwar, V. (2003). Nanotech approaches to drug delivery and imaging. Drug Discov. Today, 8, pp. 1112-1120.
113. Sahoo, S. K., Panyam, J., Prabha, S. and Labhasetwar, V. (2002). Residual polyvinyl alcohol associated with poly (,-Iactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J. Control. Rel., 82, pp. 105-114.
114. Sakthivel, T., Toth, I. and Florence, A. T. (1999). Distribution of a lipidic 2.5 nm diameter dendrimer carrier after oral administration. Int. J. Pharm., 183, pp. 51-55.
115. Salama, N. N., Eddington, N. D. and Fasano, A. (2006). Tight junction modulation and its relationship to drug delivery. Adv. Drug Deliv. Rev., 58, pp. 15-28.
116. Sandvig, K. and van Deurs, B. (2002). Membrane traffic exploited by protein toxins. Annu. Rev. Cell Dev. Biol., 18, pp. 1-24.
117. Schafer-Korting, M., Korting, H. C. and Ponce-Poschl, E. (1994). Liposomal tretinoin for uncomplicated acne vulgaris. Clin. Invest., 72(12), pp. 1086-1091.
118. Serpe, L., Guido, M., Canaparo, R, Muntoni, E., Cavalli, R, Panzanelli, P., Pepa, C. D., Bargoni, A., Mauro, A., Gasco, M. R, Eandi, M., and Zara, G. P. (2006). Intracellular accumulation and cytotoxicity of doxorubicin with different pharmaceutical formulations in human cancer cell lines. J. Nanosci. Nanotech., 6, pp.3062-3069.
119. Shenoy, D., Little, S., Langer, R. and Amiji, M. (2005). Poly(ethylene oxide)-modified poly(amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: Part 2. In vivo distribution and tumor localization studies. Pharrn. Res., 22, pp. 2107-2114.
120. Shim, J., Kang, H. S., Park, W.-S., Han, S.-H., Kim, J. and Chang, I.-S. (2004). Transdermal delivery of mixnoxidil with block copolymer nanoparticles. J. Control. Rei., 97, pp. 477-484.
121. Short, S. M., Paasch, B. D., Turner, J. H., Weiner, N., Daugherty, A. L. and Mrsny, R. J. (1996). Percutaneous absorption of biologically-active interferon-gamma in a human skin graft-nude mouse model. Pharrn. Res., 13, pp. 1020-1027.
122. Singh, B. and Florence, A. T. (2005). Hydrophobic dendrimer-derived nanoparticles. Int. J. Pharrn., 298, pp. 348-353.
123. Skirtach, A. G., Munoz Javier, A., Kreft, O., Kohler, K., Piera Alberola, A., Mohwald, H., Parak, W. J. and Sukhorukov, G. B. (2006). Laser-induced release of encapsulated materials inside living cells. Angew. Chern., 45, pp. 4612-4617.
124. Solberg, S. M. and Landry, C. C. (2006). Adsorption of DNA into mesoporous silica. J. Phys. Chern., B 110, pp. 15261-15268.
125. Sonvico, F., Dubernet, C., Colombo, P. and Couvreur, P. (2005). Metallic colloid nanotechnology, applications in diagnosis and therapeutics. Curro Pharrn. Design, II, pp. 2091-2105.
126. Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R. and Rudzinski, W. E. (2001). Biodegradable polymeric nanoparticles as drug delivery devices. J. Control. Rei., 70(1-2), pp. 1-20.
127. Steimer, A., Haltner, E. and Lehr, C.-M. (2005). Cell culture models of the respiratory tract relevant to pulmonary drug delivery. J. Aerosol Med., 18, pp. 137-182.
128. Sudimack, J. and Lee, R. J. (2000). Targeted drug delivery via the folate receptor. Adv. Drug Deliv. Rev., 41(2), pp. 147-162.
129. Tajarobi, F., El-Sayed, M., Rege, B. D., Polli, J. E. and Ghandehari, H. (2001). Transport of poly amidoamine dendrimers across Madin-Darby canine kidney cells. Int. J. Pharrn., 215(1-2), pp. 263-267.
130. Tkachenko, A. G., Xie, H., Coleman, D., Glomm, W., Ryan, J., Anderson, M. F., Franzen, S. and Feldheim, D. L. (2003). Multifunctional gold nanoparticle-peptide complexes for nuclear targeting. J. Arn. Chern. Soc., 125, pp. 4700-4701.
131. Tokuyama, H., Yamago, S., Nakamura, E., Shiraki, T. and Sugiura, Y. (1993). Photoinduced biochemical activity of fullerene carboxylic acid. J. Arn. Chern. Soc., 115(17), pp. 7918-7919.
132. Torchilin, V. P. (2005). Fluorescence microscopy to follow the targeting of liposomes and micelles to cells and their intracellular fate. Adv. Drug Deliv. Rev., 57(1), pp.95-109.
133. Torchilin, V. P., Levchenko, T. S., Rammohan, R., Volodina, N., Papahadjopoulos-Sternberg, B. and D'Souza, G. G. M. (2003). Cell transfection in vitro and in vivo with nontoxic TAT peptide-Ii po some-DNA complexes. Proc. Natl. Acad. Sci., 100, pp. 1972-1977.
134. Torchilin, V. P., Rammohan, R., Weissig, V. and Levchenko, T. S. (2001). TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc. Natl. Acad. Sci., 98, pp. 8786-8791.
135. Torchilin, V. P., Zhou, F. and Huang, L. (1993). pH-Sensitive liposomes. J. Liposame Res., 3, pp. 201-255.
136. Touitou, E., Levi-Schaffer, F., Dayan, N., Alhaique, F. and Riccieri, F. (1994). Modulation of caffeine skin delivery by carrier design: Liposomes versus permeation enhancers. Int. J. Pharm., 103(2), pp. 131-136.
137. Touitou, E., Shaco-Ezra, N., Dayan, N., Jushynski, M., Rafaeloff, R. and Azoury, R. (1992). Dyphylline liposomes for delivery to the skin. J. Pharm. Sci., 81, pp. 131- 134.
138. Trimaille, T., Pichot, C. and Delair, T. (2003). Surface functionalization of poly(,-lactic acid) nanoparticles with poly(ethy1enimine) and plasmid DNA by the layer-bylayer approach. Colloids and Surfaces A, 221, pp. 39-48.
139. Veiga, V., Ryan, D. H., Sourty, E., Llanes, F. and Marchessault, R. H. (2000). Formation and characterization of superparamagnetic cross-linked high amylose starch. Carbohydrate Polymers, 42, pp. 353-357.
140. Verma, I. M. and Somia, N. (1997). Gene therapy - Promises, problems and prospects. Nature 389, pp. 239-242.
141. Vila, A., Gill, H., McCallion, O. and Alonso, M. J. (2004). Transport of PLA-PEG particles across the nasal mucosa: Effect of particle size and PEG coating density. J. Control. Rel., 98(2), pp. 231-244.
142. Voura, E. B., Jaiswal, J. K., Mattoussi, H. and Simon, S. M. (2004). Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emissionscanning microscopy. Nat. Med., 10(9), pp. 993-998.
143. Rubas, W., Supersaxo, A., Weder, H. G., Hartmann, H. R., Hengartner, H., Schott, H. and Schwendener, R. (1986). Treatment of murine Ll210 lymphoid leukemia and melanoma B 16 with lipophilic cytosine arabinoside prodrugs incorporated into unilamellar liposomes. Int. J. Concer, 37 pp. 149-154.
144. Wang, H., Cheng, J-X., Huff, T. B., Zweifel, D. A., He, W., Low, P. S. and Wei, A. (2005). In vitro and in vivo two-photon luminescence imaging of single gold nanorods. Proc. Natl. Acad. Sci., 102, pp. 15752-15756.
145. Wang, Q., Lin, T., Tang, L., Johnson, J. E. and Finn, M. G. (2002). Icosahedral virus particles as addressable nanoscale building blocks. Angew. Chern., 41, pp. 459-462.
146. Warheit, D. B., Laurence, B. R., Reed, K. L., Roach, D. H., Reynolds, G. A. M. and Webb, T. R. (2004). Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Taxical. Sci., 77, pp. 117-125.
147. Watson, P., Jones, A. T. and Stephens, D. J. (2005a). Intracellular trafficking pathways and drug delivery: Fluorescence imaging of living and fixed cells. Adv. Drug Deliv. Rev., 57, pp. 43-61.
148. Watson, P., Jones, A. T. and Stephens, D. J. (2005b). Intracellular trafficking pathways and drug delivery: fluorescence imaging of living and fixed cells. Adv. Drug Deliv. Rev., 57, pp. 43-61.
149. Wattiaux, R., Laurent, N., Wattiaux-De Coninck, S. and Jadot, M. (2000). Endosomes, Iysosomes: their implication in gene transfer. Adv. Drug Deliv. Rev., 41, pp. 201- 208.
150. Weyhers, H., Uibenberg, R., Mehnert, W., Souto, E. B., Kreuter, J. and Muller, R. H. (2006). In vivo distribution of 125I-radiolabelled solid lipid nanoparticles. Pharrn. Ind., 68, pp. 889-894.
151. Willis, R. C. (2004). Good Things in small packages. Modern Drug Discovery, pp. 30-36.
152. Wörle-Knirsch, J. M., Pulskamp, K. and Krug, H. F. (2006). Oops they did it again! Carbon nanotubes hoax scientists in viability assays. Nano Letters, 6, pp. 1261- 1268.
153. Wu, X., Liu, H., Liu, J., Haley, K. N., Treadway, J. A., Larson, J. P., Ge, N., Peale, F. and Bruchez, M. P. (2003). Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat. Biotech., 21, pp. 41- 46.
154. Xu, Z. P., Hua Zeng, Q., Lu, G. Q. and Bing Yu, A. (2006). Inorganic nanoparticles as carriers for efficient cellular delivery. Chern. Engin. Sci., 61, pp. 1027-1040.
155. Yager, P. and Schoen, P. E. (1983). Formation of tubules by a polymerizable surfactant. Mol. Cryst. Liquid Cryst. 106, pp. 371-381.
156. Zauner, W., Farrow, N. A. and Haines, A. M. R. (2001). In vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell density. J. Control. Rel., 71, pp. 39-51.
157. Zhang, N., Ping, Q., Huang, G., Han, X., Cheng, Y. and Xu, W. (2006). Transport characteristics of wheat germ agglutinin-modified insulin-liposomes and solid lipid nanoparticles in a perfused rat intestinal model. J. Nanosci. Nanotech., 6, pp. 2959- 2966.